Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations.


Journal

Epidemiology (Cambridge, Mass.)
ISSN: 1531-5487
Titre abrégé: Epidemiology
Pays: United States
ID NLM: 9009644

Informations de publication

Date de publication:
03 2019
Historique:
entrez: 6 2 2019
pubmed: 6 2 2019
medline: 21 5 2019
Statut: ppublish

Résumé

The Swedish Multiple Sclerosis Register is a national register monitoring treatment and clinical course for all Swedish multiple sclerosis (MS) patients, with high coverage and close integration with the clinic. Despite its great value for epidemiologic research, it has not previously been validated. In this brief report, we summarize a large validation of >3,000 patients in the register using clinical chart review in the context of the COMBAT-MS study. While further improving the data quality for a central cohort of patients available for future epidemiologic research, this study also allowed us to estimate the accuracy and completeness of the register data.

Identifiants

pubmed: 30721167
doi: 10.1097/EDE.0000000000000948
pii: 00001648-201903000-00011
pmc: PMC6369893
doi:

Substances chimiques

Antirheumatic Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-233

Références

Acta Neurol Scand. 2015;132(199):11-9
pubmed: 26046553
Mult Scler. 2017 Jul;23(8):1137-1147
pubmed: 27758955
Mult Scler. 2017 Oct;23(11):1488-1495
pubmed: 27956559
Mult Scler. 2018 Apr;24(4):520-528
pubmed: 28367678
Mult Scler. 2018 May;24(6):786-794
pubmed: 28481159
Neurology. 2017 Aug 8;89(6):555-562
pubmed: 28687718
Mult Scler. 2018 Aug;24(9):1224-1233
pubmed: 28762877
Ann Neurol. 2017 Oct;82(4):554-561
pubmed: 28869671
Neurology. 2017 Dec 12;89(24):2462-2468
pubmed: 29117950
Mult Scler. 2019 Jan;25(1):104-112
pubmed: 29143553
J Neurol. 2018 Jan;265(1):108-114
pubmed: 29159463

Auteurs

Peter Alping (P)

From the Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Annette Langer-Gould (A)

Clinical and Translational Neuroscience, Southern Clinical and Translational Neuroscience, Southern California Permanente Medical Group, Kaiser Permanente, Pasadena, CA.

Thomas Frisell (T)

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH